Intermittent and continuous outpatient and home inotrope infusions have contributed to a decreased mortality rate and improved quality of life in the patient with end-stage congestive hea failure. Before the advent of noninvasive hemodynamic monitoring, available with thoracic electrical bioimpedance, initial dosage and titration were determined solely with invasively acquired data requiring hospital admission or with patients’ subjective data. Thoracic electrical bioimpedance monitoring of patients receiving inotrope therapy provides objective documentation of drug efficacy, developing tolerance, and optimal dosage.
Skip Nav Destination
Noninvasive Monitoring Using Thoracic Bioimpedance| August 01 1999
Managing Inotrope Therapy Noninvasively
AACN Adv Crit Care (1999) 10 (3): 406–413.
- Views Icon Views
- Share Icon Share
Marie Lasater; Managing Inotrope Therapy Noninvasively. AACN Adv Crit Care 1 August 1999; 10 (3): 406–413. doi:
Download citation file: